Trajenta

Trajenta Description

linagliptin

Manufacturer:

Boehringer Ingelheim
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Description
1 film-coated tablet contains 5 mg 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- (= linagliptin).
Excipients/Inactive Ingredients: mannitol, starch pregelatinised, maize starch, copovidone, magnesium stearate, Opadry Pink (02F34337).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in